Latest News

New Clinical Trial for those with Primary Progressive MS – Now recruiting

June 14, 2021 | Advocacy, Treatments, Trials

About 10% of people with MS are diagnosed with Primary Progressive Multiple Sclerosis (PPMS). While more common forms of MS involve a relapse-remit pattern (unpredictable attacks followed by periods of disease inactivity), PPMS is characterised by a slow onset and […]


Covid Vaccine update for People with MS & Webinar

June 3, 2021 | Advocacy, Covid-19, Event, Treatments, Uncategorised

Understandably, there is a high level of interest within the Multiple Sclerosis (MS) Community for information about how the Pfizer vaccine works and is impacting people with MS globally. Due to this Multiple Sclerosis New Zealand and the Ministry of […]


Call for Stem Cell treatment for MS

May 20, 2021 | Advocacy, Media, Treatments

Anne Beasley had to travel to India for Hematopoietic Stem Cell Transplant (HSCT) at the end of 2019 and at a cost of $42,000 Although it is already available in New Zealand for people with blood and bone marrow cancer, […]


Personal ‘Bangers to Bluff’ Crusade to Keep MS Patients Wheelchair-free

April 9, 2021 | Advocacy, Education, Event, Life with MS, Treatments

Media Release – For Immediate Release 8 April 2021   Personal ‘Bangers to Bluff’ Crusade to Keep MS Patients Wheelchair-free For most, the annual Rotary Club of Half Moon Bay ‘Bangers to Bluff’ event is a chance to drive from […]


Update: Ocrelizumab for Primary Progressive MS

April 9, 2021 | Advocacy, Life with MS, Treatments

At the November 2020 meeting of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) further information was reviewed to support the application for funding of Ocrelizumab for Primary Progressive MS. At this meeting PTAC recommended listing with low priority and have requested […]